2024 ASCO® Annual Meeting Insights Hub

Meeting coverage & Vumedi’s exclusive highlights, all in one place.

 

ASCO® 2024 Insights: "ALARICE Study - Avelumab With Axitinib in Persistent/Recurrent Cervical Cancer After Platinum-Based Chemo"

58 views
June 6, 2024
Comments 0
Login to view comments. Click here to Login